Market Outlook

By 2035, the U.S. Connected Medical Devices Market is expected to reach approximately USD 76.06 billion, expanding at a CAGR of 15.00% during the forecast period 2026–2035. The market is estimated at USD 18.80 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

The historical market expanded from approximately USD 10.68 billion in 2021 to USD 16.25 billion in 2024, supported by the rapid normalization of remote patient monitoring, wider adoption of continuous glucose monitoring, growth in ambulatory cardiac monitoring, connected patient-monitoring infrastructure, wireless hospital devices, cloud-linked therapeutic systems, and stronger health-system investment in digital care delivery. By 2025, connected medical devices had moved from a predominantly remote-monitoring proposition to a broader clinical infrastructure category spanning hospitals, specialty practices, ambulatory settings, post-acute care, and the home.

The U.S. market includes regulated medical devices whose clinical utility depends materially on digital connectivity, automated data transmission, remote access, interoperability, or network-enabled clinical decision support. Major revenue pools include connected patient monitors, wearable medical devices, continuous glucose monitoring systems, connected cardiac monitors, smart drug-delivery systems, networked infusion systems, connected diagnostic equipment, implantable monitoring devices, respiratory devices, and other digitally enabled therapeutic platforms. Consumer wellness products without a meaningful regulated medical function are excluded, as are general-purpose telehealth software, electronic health records, and standalone IT networking infrastructure.

The structural demand base is substantial. The United States has more than 6,000 hospitals, approximately 907,000 staffed hospital beds, and more than 35 million annual hospital admissions. At the same time, chronic diseases increasingly require longitudinal rather than episodic management. Nearly half of U.S. adults have hypertension, more than 40 million Americans are estimated to have diabetes, and more than 61 million people were aged 65 or older by 2024. These population and infrastructure conditions create a large addressable environment for continuous physiological measurement, connected therapeutics, remote surveillance, medication-management systems, and digitally coordinated post-discharge care.

From 2026 through 2035, market expansion will increasingly come from the conversion of conventional medical devices into continuously connected clinical platforms. Competitive differentiation will therefore depend less on connectivity alone and more on what manufacturers can accomplish with the resulting data. Devices that improve clinician productivity, reduce manual documentation, identify deterioration earlier, shorten intervention time, support reimbursable remote care, integrate with enterprise workflows, and reduce avoidable utilization will command disproportionate value.

The market is forecast to rise from approximately USD 21.62 billion in 2026 to USD 37.81 billion by 2030, before reaching USD 76.06 billion in 2035. This trajectory reflects both unit growth and a changing revenue model in which hardware is increasingly combined with software, analytics, cloud infrastructure, cybersecurity maintenance, monitoring services, disposable sensors, and recurring clinical-support revenue.

 

Introduction

According to the U.S. Connected Medical Devices Market Report, connectivity is becoming part of the fundamental architecture of medical technology rather than a premium feature. Hospitals, physicians, payers, patients, and device manufacturers increasingly depend on connected systems to move physiological data between patients, devices, clinical teams, electronic records, analytic engines, and care-management platforms.

The economic logic behind adoption is particularly strong in the United States because clinical labor is expensive, hospital capacity is constrained, chronic disease management is fragmented, and health systems face pressure to manage patients across a wider continuum of care. A connected device can create value by replacing manual measurements, reducing transcription, improving surveillance coverage, prioritizing higher-risk patients, allowing earlier discharge, enabling home-based monitoring, or improving adherence to therapy. Buyers are therefore evaluating connected devices through workflow and episode-of-care economics rather than hardware specifications alone.

Connectivity also changes the relationship between a device manufacturer and the customer. A conventional device may generate most of its economic value at the time of purchase or procedure. A connected device can remain integrated into the care pathway for months or years through cloud analytics, remote device management, software upgrades, alerts, patient applications, cybersecurity updates, replacement sensors, consumables, and longitudinal data services. This creates more recurring commercial models but also increases vendor responsibility for uptime, interoperability, data protection, software quality, and postmarket support.

The U.S. regulatory environment is reinforcing this transition. Medical devices that include software, connect to the internet, and contain technological characteristics that may create cybersecurity exposure can fall within federal requirements applicable to “cyber devices.” Manufacturers entering or updating the U.S. market increasingly need lifecycle plans for vulnerability management, secure product development, patching, coordinated vulnerability disclosure, and postmarket cyber maintenance. Cybersecurity has consequently become both a regulatory requirement and a hospital procurement criterion.

Reimbursement is another market-enabling factor. Remote patient monitoring models allow clinicians to use connected medical devices to collect and transmit physiological data such as blood pressure, weight, glucose, oxygen saturation, and other health parameters. This creates an economic pathway for connected devices to become part of recurring clinical care rather than optional technology purchases. The commercial opportunity is strongest when device deployment is integrated into physician workflow, patient onboarding, data review, escalation protocols, billing processes, and clinical documentation.

For this report, market sizing captures the value of connected regulated medical devices and closely associated device-embedded digital capabilities sold into U.S. healthcare. It excludes broad digital-health software that does not require a medical device, consumer electronics used solely for wellness, telecom infrastructure, and enterprise IT platforms unrelated to medical-device operation. This boundary is important because broader definitions can materially overstate the addressable medical-device revenue pool.

 

Key Market Drivers: What’s Fueling the U.S. Connected Medical Devices Market Boom?

The first major driver is the scale of chronic disease in the United States. Connected medical devices are particularly valuable when a patient’s physiological status changes continuously and cannot be managed effectively through occasional office visits. Hypertension affects approximately 47.7% of U.S. adults, while diabetes affects an estimated 40.1 million Americans. These conditions create recurring demand for blood pressure monitoring, continuous glucose monitoring, connected weight measurement, cardiovascular surveillance, medication adherence technologies, and other home-based measurement systems.

Diabetes is one of the clearest examples of how connectivity can transform an established device category. Continuous glucose monitors have shifted diabetes care from isolated glucose readings toward continuous data streams, trend analysis, alerts, smartphone integration, remote data sharing, and increasingly automated therapeutic decision-making. As sensor duration improves and integration between glucose monitors, insulin pumps, digital platforms, and clinical teams deepens, diabetes remains one of the most commercially important connected-device ecosystems in the country.

A second driver is the aging U.S. population. More than 61 million Americans were aged 65 or older in 2024. Older adults consume disproportionately high levels of healthcare and are more likely to have cardiovascular disease, diabetes, respiratory conditions, sleep disorders, mobility limitations, heart failure, and multiple chronic conditions. Connected devices can extend specialist oversight into the home while reducing travel burdens and supporting earlier recognition of deterioration.

A third driver is hospital capacity and labor economics. The U.S. hospital system includes approximately 907,000 staffed beds and more than 35 million annual admissions. Nursing shortages, clinician burnout, rising wages, and increased patient acuity are encouraging health systems to automate routine measurements and extend monitoring beyond the ICU. Wireless wearable monitoring, centralized surveillance, connected vital-sign systems, smart beds, networked infusion devices, and mobile clinical alerts can help care teams supervise more patients without replicating high-intensity bedside staffing models throughout the hospital.

A fourth driver is the migration of care into ambulatory and home settings. Health systems increasingly seek to discharge appropriate patients earlier, avoid preventable readmissions, manage chronic conditions remotely, and redirect selected diagnostic and therapeutic activity away from expensive inpatient settings. Connected devices enable this transition by preserving clinical visibility after patients leave the hospital. Commercial opportunities are therefore expanding in hospital-at-home programs, specialty RPM programs, post-surgical monitoring, cardiac care, sleep medicine, diabetes management, pulmonary care, and post-acute services.

A fifth driver is reimbursement-supported remote patient monitoring. Connected devices that automatically transmit health information can form the technical foundation of reimbursable remote monitoring programs. The economic opportunity extends beyond device sales because successful programs require patient enrollment, device logistics, connectivity, dashboards, data management, clinician review, escalation protocols, documentation, and ongoing support. Manufacturers that reduce operational complexity for providers can therefore capture more value than companies that simply supply measurement hardware.

A sixth driver is the growing importance of continuous rather than intermittent data. Traditional healthcare has relied heavily on measurements collected during scheduled encounters. Connected medical devices make it possible to observe physiological trends between visits, during recovery, overnight, and while patients perform normal activities. This can reveal deterioration, arrhythmias, glucose excursions, blood-pressure variability, respiratory changes, treatment non-adherence, or other clinically relevant patterns that may be invisible during a brief office assessment.

A seventh driver is improving wireless infrastructure and device miniaturization. Low-power Bluetooth, Wi-Fi, cellular connectivity, smaller sensors, edge computing, longer battery life, improved adhesives, miniaturized electronics, and more efficient cloud architectures are allowing medical devices to collect more data while placing less physical burden on patients. The result is a larger universe of wearable, patch-based, implantable, portable, and home-based medical technologies.

An eighth driver is hospital interest in enterprise standardization. Large U.S. health systems increasingly want connected-device ecosystems that can scale across multiple facilities rather than isolated point solutions. Vendors able to provide interoperable monitoring, device management, cybersecurity governance, analytics, centralized surveillance, and electronic medical record integration can compete for enterprise-wide agreements. This shift favors companies with broad platforms, strong service networks, and the ability to support complex IT environments.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation is moving from basic device connectivity toward clinically actionable connectivity. Sending a measurement to the cloud is no longer sufficient differentiation. The next generation of products must determine how the information should be filtered, interpreted, escalated, documented, and incorporated into clinical decisions.

Wearable medical monitoring is one of the fastest-moving areas. Newer platforms combine continuous measurement with wireless data transmission while reducing patient tethering. Hospitals are using wearable monitoring to extend surveillance from intensive-care environments into general wards, post-operative units, step-down units, and ambulatory pathways. The strategic value lies in giving clinicians continuous physiological visibility without forcing the patient to remain physically connected to a bedside monitor.

Continuous glucose monitoring remains another major innovation platform. Sensor life is extending, device profiles are becoming smaller, connectivity is improving, and data-sharing ecosystems are becoming more sophisticated. Longer-wear sensors can improve convenience and reduce replacement frequency while supporting larger recurring revenue pools. Integration with insulin delivery creates an even higher-value connected therapeutic ecosystem in which sensing, algorithmic interpretation, and medication administration become progressively linked.

Cardiac monitoring is evolving from conventional Holter recording toward longer-duration adhesive patches, mobile cardiac telemetry, implantable monitors, smartphone-enabled ECG systems, and cloud-based diagnostic workflows. The clinical value is not simply more data. The competitive objective is to identify clinically relevant events without overwhelming physicians with noise. Algorithm quality, report turnaround, workflow integration, diagnostic yield, wear duration, patient compliance, and physician service models are therefore becoming central competitive variables.

Connected therapeutic systems are also becoming more sophisticated. Insulin pumps, infusion systems, respiratory devices, implantable cardiac devices, dialysis systems, and other therapeutic technologies can increasingly transmit status information, usage data, alarms, therapy parameters, and device performance information. This gives manufacturers opportunities to improve adherence, support predictive maintenance, reduce device downtime, and remotely identify problems before they affect treatment.

Artificial intelligence is becoming an intelligence layer across connected-device ecosystems. AI-enabled medical technologies are increasingly used in imaging, ECG interpretation, physiological monitoring, patient deterioration detection, workflow prioritization, and diagnostic support. For connected devices, the critical commercial opportunity is combining longitudinal data with algorithms capable of identifying which changes require clinician attention. The economic value of AI will be highest when it reduces false alarms, improves triage, decreases review time, or creates earlier actionable intervention.

Edge computing is emerging as another important design direction. Not every medical-device decision can depend on continuous cloud connectivity. Processing information closer to the patient or within the hospital network can improve latency, resilience, data minimization, and operational continuity. Hybrid architectures that combine device-level intelligence, edge processing, and cloud analytics are likely to become increasingly common in high-acuity connected systems.

Cybersecurity-by-design is becoming an innovation requirement rather than a compliance afterthought. Manufacturers must increasingly design products around secure authentication, encryption, access control, software-bill-of-materials management, vulnerability monitoring, patchability, logging, network segmentation compatibility, and postmarket update mechanisms. Hospitals evaluating major connected-device fleets increasingly want to know how long the manufacturer will support security updates and what happens when software components become obsolete.

Interoperability is equally important. Connected devices generate limited value if clinicians must manually move information between proprietary applications. Device vendors are therefore investing in standards-based exchange, APIs, electronic medical record integration, centralized device management, and shared clinical dashboards. In procurement evaluations, interoperability can materially influence total implementation cost and time to clinical adoption.

The long-term innovation direction is toward closed-loop or semi-automated care. Connected sensing creates the input layer, analytics interpret the data, and therapeutic systems can then adjust treatment or prompt clinician action. Diabetes technology is already demonstrating this model through integrated glucose sensing and insulin delivery. Similar concepts are likely to influence cardiovascular management, respiratory care, neurostimulation, medication management, and other therapeutic categories during the forecast period.

 

Segmentation Insights

The U.S. Connected Medical Devices Market is segmented on the basis of device type, connectivity technology, application, end user, and region.

 

By Device Type

Connected Patient Monitoring Devices

Connected patient monitoring devices represent one of the largest revenue categories because monitoring is the most natural use case for continuous connectivity. The segment includes vital-sign monitors, ECG systems, blood-pressure monitors, pulse oximeters, respiratory monitors, connected weight scales, temperature monitors, mobile cardiac telemetry, and multi-parameter platforms. Growth is being driven by both hospital modernization and expansion of monitoring into home-based care.

U.S. hospitals are increasingly evaluating continuous monitoring outside intensive-care units to identify deterioration earlier and reduce dependence on periodic manual observations. At the same time, cardiology, hypertension, heart failure, pulmonary, and post-discharge programs are using connected monitors to extend observation beyond the hospital. The strongest products combine reliable sensing with manageable alert volumes, straightforward patient onboarding, automated data transmission, and clinician-friendly dashboards.

Wearable Medical Devices

Wearable medical devices are expected to be among the fastest-growing device categories through 2035. Medical-grade patches, biosensors, wearable ECG devices, continuous glucose monitors, medical watches, sleep-monitoring systems, and other body-worn technologies allow longer observation without materially restricting patient mobility.

The segment benefits from improved sensor miniaturization, battery efficiency, wireless performance, adhesives, smartphone integration, and patient familiarity with wearable technology. However, U.S. healthcare buyers distinguish clearly between consumer wellness wearables and regulated medical devices. Commercial success depends on validated clinical performance, FDA authorization where required, dependable data capture, adherence, reimbursement relevance, and integration into a defined care workflow.

Connected Therapeutic and Drug-Delivery Devices

Connected therapeutic devices include insulin pumps, smart infusion systems, respiratory therapy devices, dialysis equipment, neurostimulation technologies, medication-delivery systems, and other devices in which connectivity contributes to treatment management.

This category is strategically attractive because connectivity can influence not only observation but therapy execution. Manufacturers can remotely track device status, treatment adherence, consumable use, alarms, performance, and selected therapy parameters. The resulting data can support clinical management, patient engagement, device servicing, and recurring commercial relationships. Connected insulin delivery is a particularly advanced ecosystem because of its growing integration with continuous glucose sensing.

Connected Diagnostic and Imaging Devices

Connected diagnostic devices include network-enabled diagnostic systems, point-of-care technologies, portable imaging platforms, ultrasound systems, selected laboratory devices, connected screening technologies, and diagnostic equipment that exchanges data with clinical information systems.

Demand is being driven by workflow integration and the need to make diagnostic data available rapidly across distributed health systems. U.S. providers increasingly favor devices that automatically associate results with the correct patient, transfer results to clinical systems, support remote review, reduce manual entry, and enable centralized fleet management. Connectivity also allows manufacturers to provide remote service, software updates, performance monitoring, and utilization analytics.

Connected Implantable Medical Devices

Connected implantable devices include implantable cardiac monitors, pacemakers, defibrillators, cardiac resynchronization systems, selected neurostimulation devices, implantable hemodynamic monitors, and other implants capable of transmitting data outside the body.

Although smaller by unit volume than external monitoring, connected implantables generate high clinical and economic value because they can provide long-duration surveillance in patients with significant disease burden. Remote interrogation can reduce routine in-person visits while allowing clinicians to identify device status changes or clinically relevant events. Competition is shaped by implant longevity, transmission reliability, algorithm performance, clinician workflow, cybersecurity, and the installed base of remote-monitoring infrastructure.

 

By Connectivity Technology

Wi-Fi

Wi-Fi remains a dominant connectivity technology within hospitals because health systems already operate extensive wireless infrastructure. It supports patient monitors, diagnostic platforms, infusion systems, imaging equipment, mobile devices, and other network-connected technologies.

Its major advantages include bandwidth, established enterprise management, and integration with hospital systems. Its challenges include network congestion, roaming performance, cybersecurity, wireless coexistence, authentication, and dependency on hospital IT configuration. Manufacturers increasingly need strong enterprise networking capabilities because a clinically effective device can still fail commercially if implementation creates excessive burden for hospital IT teams.

Bluetooth and Bluetooth Low Energy

Bluetooth and Bluetooth Low Energy are central to wearable and home-based medical-device ecosystems. They allow low-power communication between sensors and smartphones, hubs, tablets, or dedicated gateways. BLE is particularly attractive where battery life, small device size, and patient convenience are important.

Its role is expanding in continuous glucose monitoring, pulse oximetry, wearable ECG, blood-pressure monitoring, medical watches, respiratory devices, and other portable applications. Manufacturers must nevertheless manage pairing reliability, smartphone compatibility, firmware updates, data synchronization, and usability for older or less technically confident patients.

Cellular, LTE, and 5G Connectivity

Cellular connectivity is expected to record some of the fastest growth through 2035 because it can reduce dependence on a patient’s home Wi-Fi or personal smartphone. Dedicated cellular devices are especially relevant for remote monitoring programs where providers want predictable data transmission and simpler patient onboarding.

5G will become more strategically important as latency-sensitive applications, higher-bandwidth device data, mobile imaging, edge computing, and more complex connected-care architectures develop. The near-term value proposition, however, remains operational reliability rather than speed alone.

NFC and RFID

NFC and RFID technologies are important in device identification, authentication, inventory management, patient association, medication workflows, asset tracking, and selected near-field medical-device interactions. These technologies generally generate less direct device revenue than Wi-Fi or Bluetooth but support safer and more automated clinical workflows.

Their role will expand as hospitals seek better visibility into device fleets, consumable inventory, medication administration, procedure-room assets, and patient-device matching. Integration with broader hospital asset-management and supply-chain systems will determine their commercial value.

Other Wireless and Hybrid Technologies

Other technologies include proprietary radio protocols, low-power wide-area networking, wired-plus-wireless hybrid architectures, and emerging connectivity models designed for specific clinical use cases. High-acuity systems may deliberately use multiple communication pathways to improve resilience.

The long-term trend is toward connectivity abstraction, in which clinicians should not need to manage the underlying communication technology. Device success will increasingly be measured by whether information reaches the right clinical destination reliably rather than which radio protocol performs the transmission.

 

By Application

Remote Patient Monitoring and Chronic Disease Management

Remote patient monitoring is expected to be the fastest-growing application through 2035. The addressable population includes patients with hypertension, diabetes, heart failure, arrhythmias, respiratory disease, post-operative needs, obesity-related conditions, and other chronic or transitional-care requirements.

The strongest RPM programs are not simple device-distribution businesses. They integrate patient selection, onboarding, measurement adherence, data transmission, exception management, clinician review, billing, escalation, and documentation. Device suppliers that simplify these operational steps can increase provider adoption and reduce program abandonment.

Inpatient Patient Monitoring and Clinical Workflow

Hospitals remain a major application environment for connected medical devices. Wireless vital-sign monitoring, centralized surveillance, networked bedside devices, smart infusion, connected respiratory equipment, and interoperable diagnostic systems are becoming part of hospital infrastructure.

The purchasing logic is increasingly based on workforce productivity, patient safety, alarm management, interoperability, cyber resilience, and system-wide standardization. Hospitals want connected devices that reduce rather than add to clinical complexity.

Cardiac and Vital-Sign Monitoring

Cardiac monitoring is a high-value application because intermittent symptoms and episodic arrhythmias frequently require longer observation periods. Connected ECG patches, mobile cardiac telemetry, implantable cardiac monitors, smart ECG systems, and remote monitoring of implanted rhythm devices allow clinicians to evaluate patients over days, weeks, or years.

The market is moving toward longer wear, more automated analysis, improved signal quality, better arrhythmia detection, and streamlined physician reporting. Algorithm performance must be balanced with manageable review burden because excessive false alerts can reduce the economic value of continuous monitoring.

Diabetes and Metabolic Management

Diabetes represents one of the most mature and commercially successful connected-device applications. Continuous glucose monitoring has created a recurring sensor-based model with high patient engagement, while connected insulin pumps and algorithm-driven therapy are creating increasingly integrated diabetes ecosystems.

The U.S. diabetes population exceeds 40 million people, creating significant long-term demand. Growth will be supported by wider CGM eligibility, longer-wear sensors, improved affordability, type 2 diabetes penetration, pharmacy distribution, integration with insulin delivery, and clinician familiarity with continuous glucose data.

Medication Delivery, Post-Acute Care, and Other Applications

Connected medication-delivery systems, post-discharge monitoring devices, respiratory equipment, sleep technologies, rehabilitation systems, and other applications form a diverse but expanding category.

Post-acute care is particularly attractive because health systems increasingly remain economically exposed to complications after discharge. Technologies that can identify deterioration, confirm therapy adherence, or provide clinicians with actionable information before an emergency visit can create measurable value under risk-based care models.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated delivery networks represent the largest institutional buyers. They purchase connected patient monitors, infusion systems, diagnostic platforms, implantable-device infrastructure, monitoring software, and enterprise connectivity solutions.

Large systems increasingly standardize vendors across multiple hospitals to simplify training, interfaces, cybersecurity governance, service contracts, and supply chains. Winning an enterprise agreement can therefore create substantial recurring revenue but requires extensive clinical, technical, and implementation support.

Specialty Clinics and Physician Practices

Cardiology, endocrinology, pulmonology, sleep medicine, nephrology, neurology, and other specialties are significant users of connected devices. Specialty practices often adopt technologies when they create reimbursable services, improve diagnostic yield, reduce staff workload, or allow more frequent patient oversight without requiring additional office visits.

The market opportunity is particularly strong for solutions that arrive with operational support rather than requiring practices to build their own monitoring infrastructure.

Home Care and Remote Monitoring Providers

Home-based care is expected to record the fastest end-user growth. The segment includes hospital-at-home programs, disease-management companies, RPM service providers, home health organizations, virtual care platforms, and health-system-owned remote care programs.

Products for this setting must perform reliably outside controlled clinical environments. Ease of setup, connectivity independence, battery life, patient support, logistics, replacement workflows, cellular options, and intuitive use become as important as clinical specifications.

Ambulatory Surgery Centers and Post-Acute Facilities

Ambulatory surgery centers, rehabilitation providers, skilled nursing facilities, and other post-acute settings are adopting connected technologies selectively. These facilities require systems with lower infrastructure complexity and strong economic justification.

Post-procedure monitoring, respiratory surveillance, connected vital signs, rehabilitation sensors, smart medication management, and selected diagnostic devices can help these settings manage increasing patient acuity while maintaining lean staffing models.

Diagnostic Centers, Laboratories, and Other Providers

Diagnostic imaging centers, independent laboratories, urgent-care operators, retail clinical sites, and other decentralized providers represent an emerging connected-device customer base. The key requirement is efficient transfer of device-generated information into the provider’s clinical workflow.

As diagnostic care decentralizes, portable and connected systems that reduce manual documentation and allow centralized interpretation can gain market share.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Connected Medical Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional opportunity differs according to population growth, age distribution, chronic disease burden, hospital density, specialist availability, health-system consolidation, broadband and digital infrastructure, concentration of technology companies, reimbursement mix, and willingness to adopt remote-care models.

In 2025, the South is estimated to represent approximately USD 6.58 billion, followed by the West at USD 4.70 billion, the Northeast at USD 4.14 billion, and the Midwest at USD 3.38 billion. The West is expected to record the fastest growth through 2035, while the South should remain the largest regional market by absolute revenue.

South

The South represents approximately 35% of the national market in 2025, with an estimated value of USD 6.58 billion. It is projected to approach USD 26.35 billion by 2035, representing an implied CAGR of approximately 14.88%.

The region benefits from the largest population base, rapid migration into major metropolitan areas, a substantial Medicare population, high diabetes and cardiovascular burden, expanding hospital systems, and major rural-access challenges that can make remote monitoring economically valuable.

Texas is the region’s most important state market. Houston, Dallas-Fort Worth, Austin, and San Antonio contain large health systems, academic centers, specialty practices, and technology-intensive provider networks. Texas also combines large metropolitan demand with extensive rural areas, creating opportunities for both enterprise hospital connectivity and home-based remote monitoring.

Florida is a major connected-device market because of its large older population and high demand for cardiac, diabetes, respiratory, and post-acute care. Continuous monitoring, implanted-device follow-up, CGM, connected sleep technologies, blood-pressure monitoring, and hospital-at-home infrastructure are particularly relevant.

North Carolina combines fast population growth with sophisticated academic and integrated health systems. The Research Triangle also supports digital-health and life-science innovation. Georgia is being driven by Atlanta’s major hospital systems, expanding suburbs, and large chronic-disease population. Virginia benefits from strong integrated-provider networks, advanced specialty medicine, defense and federal healthcare activity, and high digital adoption in major metropolitan areas.

Tennessee is strategically important because Nashville is a major U.S. healthcare corporate center, while Memphis and other urban markets support large patient populations. Connected monitoring platforms can gain traction through health-system headquarters located in the state even when deployment subsequently occurs across multiple U.S. regions.

Maryland has a sophisticated hospital and research environment shaped by Baltimore, Washington-area provider networks, federal institutions, and a strong biomedical sector. South Carolina is benefiting from population growth and rising healthcare investment in Charleston, Greenville, Columbia, and coastal retirement markets.

Alabama and Mississippi have high chronic-disease burdens that create clinical need for diabetes, hypertension, cardiac, and respiratory monitoring, although adoption can be constrained by rural infrastructure and provider economics. Louisiana combines large urban medical markets with significant chronic-disease burden and access disparities.

Kentucky and West Virginia are attractive for remote monitoring because cardiovascular, pulmonary, diabetes, and rural-access challenges create a strong clinical rationale for care models that reduce unnecessary travel. Arkansas has similar demand characteristics, particularly in chronic-disease management and regional referral networks.

Oklahoma benefits from major Oklahoma City and Tulsa health systems while also presenting large rural-monitoring opportunities. Delaware, although small, has concentrated provider networks and relatively accessible health-system procurement. Collectively, these states make the South highly attractive for manufacturers capable of serving both large urban IDNs and lower-density remote-care populations.

West

The West accounted for an estimated USD 4.70 billion in 2025 and is projected to reach approximately USD 21.60 billion by 2035, representing an estimated 16.48% CAGR, the fastest of the four U.S. regions.

The West combines high technology adoption, strong digital infrastructure, medtech investment, venture-backed innovation, large integrated delivery networks, and fast-growing Sun Belt populations. It is likely to gain national market share as connected medical devices become more software-driven, consumer-accessible, and integrated with home-based care.

California is the largest connected-medical-device state market in the West and one of the largest nationally. The state combines more than 39 million residents, internationally recognized academic medical centers, leading integrated health systems, strong commercial insurance penetration, a major medtech industry, digital-health innovation, and significant venture capital. California is especially important for CGM, AI-supported devices, wearable medical monitoring, connected imaging, digital cardiology, and hospital-at-home programs.

Washington has sophisticated integrated health systems and a technology-oriented population, supporting rapid adoption of connected clinical infrastructure and remote care. Oregon has a similarly strong environment for integrated care, remote monitoring, and digitally coordinated population health.

Arizona is a high-growth market because of rapid population expansion, large retirement communities, and increasing specialty-care infrastructure in Phoenix and Tucson. Nevada is expanding from a historically capacity-constrained healthcare market as Las Vegas and Reno add hospitals and specialty services. Both states offer significant opportunities in home monitoring, cardiac care, diabetes technologies, and post-acute surveillance.

Colorado has a young, digitally engaged population alongside major integrated health systems in Denver and a strong life-sciences environment. Utah combines rapid population growth, sophisticated provider organizations, and a technology-oriented economy, making it attractive for remote monitoring and data-intensive medical-device platforms.

New Mexico has a lower population density and significant rural and underserved communities, creating a strong clinical case for connected care despite more challenging provider economics. Idaho is experiencing rapid population growth that is increasing demand for scalable health infrastructure and virtual specialty access.

Montana and Wyoming are smaller device markets but particularly relevant for remote monitoring because patients may travel long distances for specialty care. Alaska presents an extreme version of the geographic-access use case, with remote communities making connected physiological monitoring and telehealth-linked devices strategically important.

Hawaii has an older population and geographic fragmentation across islands, which supports remote specialist oversight and home monitoring. The West as a whole is expected to benefit disproportionately from AI-enabled medical devices, sensor-based digital health technologies, and increasingly consumer-friendly medical wearables.

Northeast

The Northeast represented approximately USD 4.14 billion in 2025 and is expected to reach around USD 15.64 billion by 2035, implying a CAGR of approximately 14.22%.

The region has slower population growth than the South or West but remains one of the highest-value connected-device markets because of its concentration of academic medical centers, specialist physicians, clinical research, premium hospital systems, medtech companies, and evidence-driven technology adoption.

New York is the largest market in the region. New York City contains some of the country’s largest academic and integrated health systems, while upstate markets create opportunities for remote specialist care. Connected patient monitoring, digital cardiology, diabetes systems, remote implant follow-up, hospital-at-home programs, and AI-assisted diagnostics are all important categories.

Pennsylvania has a large population, major health systems in Philadelphia and Pittsburgh, extensive academic medicine, and significant rural communities outside its metropolitan corridors. These characteristics support both sophisticated hospital connectivity and remote chronic-disease management.

Massachusetts is disproportionately important relative to population because of Boston’s globally influential academic hospitals, biotechnology sector, medtech ecosystem, and concentration of clinical trials. Connected medical-device companies often view Massachusetts institutions as early evidence-generation and reference sites.

New Jersey benefits from dense population, proximity to New York and Philadelphia, a large pharmaceutical and medical-technology industry, and strong specialty-provider networks. Connecticut has high-income commercial markets, established health systems, and an aging population that supports connected chronic-care demand.

Maine, New Hampshire, and Vermont are smaller markets but important examples of how connected medical devices can address rural geography, aging populations, and specialist-access limitations. RPM, cardiology monitoring, pulmonary monitoring, sleep technologies, and home-based devices have clear relevance.

Rhode Island is small in absolute value but benefits from dense healthcare access and academic-provider influence. Overall, Northeast procurement tends to be evidence intensive. Manufacturers often need strong clinical validation, cybersecurity documentation, integration capabilities, and health-economic evidence before large systems will standardize a platform.

Midwest

The Midwest accounted for approximately USD 3.38 billion in 2025 and is forecast to reach about USD 12.47 billion by 2035, representing an implied CAGR of approximately 13.94%.

The region offers a stable base of mature hospital systems, large cardiovascular and diabetes populations, major academic centers, nationally recognized medical-device clusters, and extensive rural healthcare networks. Procurement is frequently value focused, with health systems emphasizing implementation support, service reliability, cost per monitored patient, and enterprise scalability.

Illinois is the region’s largest market, led by Chicago’s academic hospitals, large IDNs, specialty practices, and substantial patient volumes. Ohio has several nationally influential health systems and specialty centers, making it an important launch and reference market for connected monitoring and digital medical technologies.

Michigan supports significant demand through Detroit, Ann Arbor, Grand Rapids, and other healthcare centers. Chronic cardiovascular and metabolic disease creates a strong remote-monitoring use case. Minnesota is strategically important because of its world-class medtech ecosystem and history of cardiovascular-device innovation. The state has influence beyond its population size.

Indiana combines Indianapolis health systems, life-science companies, and substantial community-hospital networks. Wisconsin has large integrated health systems and strong adoption potential for standardized connected monitoring platforms.

Missouri is anchored by major St. Louis and Kansas City health systems. Iowa combines an important academic center with distributed rural care needs. Kansas similarly benefits from regional referral networks where connected care can extend specialty support beyond urban facilities.

Nebraska, North Dakota, and South Dakota are smaller in revenue but are strategically relevant for connected medicine because of long travel distances, rural hospitals, and consolidated regional referral systems. Remote cardiac monitoring, connected blood-pressure systems, diabetes technologies, and home-based surveillance can have high clinical utility in these states.

The Midwest is unlikely to outgrow the West or South in percentage terms, but it should remain a dependable market for enterprise patient-monitoring modernization, connected cardiovascular systems, diabetes technologies, infusion infrastructure, and rural remote-care platforms.

 

Key Market Players

The U.S. Connected Medical Devices Competitive Landscape is fragmented across several overlapping ecosystems. Large diversified medtech companies compete through enterprise hospital platforms, implantable-device franchises, patient monitoring, infusion systems, imaging, and therapeutic technologies. Specialized digital-device companies compete through focused positions in glucose monitoring, cardiac diagnostics, wearable sensing, sleep medicine, and remote patient management.

Competition is moving from individual devices toward connected ecosystems. The strongest companies are increasingly combining hardware, disposable sensors, software, cloud connectivity, clinician dashboards, analytics, cybersecurity support, device fleet management, and electronic-record integration. This creates higher switching costs and allows vendors to negotiate broader enterprise agreements.

Major participants in the U.S. Connected Medical Devices Market include Abbott Laboratories, Medtronic, GE HealthCare, Philips, Siemens Healthineers, Baxter International, DexCom, Boston Scientific Corporation, Johnson & Johnson MedTech, Masimo Corporation, iRhythm Technologies, ResMed, Becton Dickinson, Insulet Corporation, Tandem Diabetes Care, Omron Healthcare, BioIntelliSense, AliveCor, ZOLL Medical Corporation, Edwards Lifesciences, Nihon Kohden America, Roche Diagnostics, Dräger, Mindray North America, and Fresenius Medical Care.

Abbott and DexCom have particularly strong positions in connected glucose sensing, while Insulet and Tandem Diabetes Care participate in connected insulin-delivery ecosystems. Medtronic combines diabetes, implantable cardiac devices, monitoring, and therapeutic platforms. Boston Scientific and Abbott maintain substantial remote cardiac-device monitoring capabilities, while iRhythm and AliveCor compete in digitally enabled ECG and arrhythmia detection.

GE HealthCare, Philips, Siemens Healthineers, Masimo, Nihon Kohden, Mindray, and Dräger are important participants in networked hospital monitoring and diagnostic infrastructure. Baxter and Becton Dickinson have substantial positions in infusion and medication-delivery workflows. ResMed has a major connected respiratory and sleep-care installed base, while Fresenius Medical Care participates in increasingly digital dialysis and renal-care models.

Market share through 2035 will be influenced by more than device performance. Hospitals will evaluate cybersecurity maturity, software-support commitments, interoperability, wireless reliability, ease of integration, clinical evidence, clinician training, patient adherence, technical service, consumable economics, reimbursement support, and the ability to deploy platforms across multiple care settings.

Manufacturers with broad installed bases have an advantage because connectivity becomes more valuable as additional devices join the same ecosystem. However, specialized companies can still gain share by solving narrow but economically important workflow problems more effectively than diversified incumbents.

 

Recent Developments

Recent U.S. developments demonstrate that the connected medical-device market is moving simultaneously toward longer-duration sensing, hospital mobility, remote surveillance, AI-enabled interpretation, and stronger cybersecurity governance.

In 2025, the Dexcom G7 15 Day continuous glucose monitoring system received U.S. FDA clearance for adults with diabetes. Longer sensor wear is strategically significant because it can reduce replacement frequency, improve patient convenience, and strengthen the economics of continuous glucose monitoring while maintaining a recurring sensor model.

Connected hospital monitoring is also evolving. GE HealthCare has expanded its Portrait ecosystem through wearable and portable vital-sign technologies designed to transmit patient information while allowing mobility. The broader trend is toward moving continuous surveillance beyond traditional ICU bedside monitoring and into general wards without recreating the physical tethering of conventional systems.

Masimo has expanded the connected wearable-monitoring model through integration of its medical watch technologies with remote telemonitoring infrastructure. This reflects a wider industry shift toward devices that can operate in both institutional and home settings, allowing the same physiological measurement architecture to support post-discharge and chronic-care workflows.

Cardiac monitoring continues to become more digital and distributed. Patch-based ECG, mobile cardiac telemetry, remote implantable-device monitoring, and cloud-supported rhythm analysis are moving more diagnostic activity outside conventional cardiology offices. Device manufacturers are competing on wear duration, patient adherence, algorithmic triage, reporting quality, clinical-service integration, and physician workflow.

The FDA’s expanding lists of sensor-based digital health technologies and AI-enabled medical devices demonstrate how quickly regulated medical technology is moving toward software-intensive and connected architectures. Recent authorized products span glucose monitoring, cardiac monitoring, neurological monitoring, sleep assessment, hemodynamic monitoring, and other applications, suggesting that connectivity is becoming a horizontal technology layer across medical specialties rather than a standalone market niche.

Cybersecurity regulation is also materially affecting product development. Federal requirements for cyber devices place greater responsibility on manufacturers to plan for vulnerability management, secure product development, patches, and postmarket cyber maintenance. By 2035, cybersecurity support periods may become an important determinant of device replacement cycles and hospital vendor selection.

Hospital procurement is consequently changing. Connected devices increasingly involve joint evaluation by clinicians, biomedical engineering, information technology, cybersecurity teams, procurement departments, and value-analysis committees. A device that performs well clinically but requires expensive integration, creates unmanaged network risk, or has an unclear software-support roadmap can face adoption barriers.

The next development phase will center on ecosystem integration. Continuous sensing, remote therapy management, AI-supported triage, clinician dashboards, electronic medical records, patient applications, and connected therapeutics are increasingly converging. Manufacturers that control or integrate multiple layers of this workflow are likely to capture more recurring value than those competing primarily on hardware specifications.

 

Conclusion

The U.S. Connected Medical Devices Market Size & Share is positioned to expand from approximately USD 18.80 billion in 2025 to USD 76.06 billion by 2035, representing a 15.00% CAGR during the 2026–2035 forecast period.

The market’s long-term growth is supported by structural healthcare needs rather than temporary digital-health enthusiasm. The United States has a large chronic-disease population, more than 61 million adults aged 65 and older, more than 6,000 hospitals, significant clinical labor constraints, an expanding home-care ecosystem, established remote-monitoring reimbursement pathways, and one of the world’s deepest medical-technology innovation environments.

The highest-value opportunities will occur where connectivity changes clinical economics. Continuous glucose monitoring, connected insulin delivery, remote cardiac diagnostics, wireless inpatient monitoring, implantable-device surveillance, connected respiratory systems, smart infusion, home-based vital-sign monitoring, and AI-supported physiological analytics are expected to attract substantial investment.

Hospital purchasing behavior will become increasingly demanding. Health systems will expect connected products to deliver measurable clinical value while fitting into cybersecurity, networking, electronic-record, biomedical engineering, and enterprise procurement requirements. Total cost of ownership will include software subscriptions, implementation, integration, device management, cybersecurity maintenance, training, support, disposable sensors, and replacement cycles.

Remote patient monitoring will remain a central growth engine, but the winning commercial models will extend beyond shipping devices to patients. Providers need complete operating systems for identifying eligible patients, onboarding them, maintaining connectivity, monitoring adherence, triaging data, documenting clinical activity, escalating risk, and integrating information into routine workflows.

Regional opportunity will be led by the South in absolute value because of its population scale, chronic-disease burden, aging population, and rapidly expanding health systems. The West is expected to grow fastest because of technology adoption, medtech innovation, high digital maturity, and strong population growth. The Northeast will remain an influential early-adoption and evidence-generation market, while the Midwest will provide stable enterprise demand and significant opportunity in rural connected care.

At the state level, California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Massachusetts, North Carolina, Georgia, Washington, Arizona, Michigan, Minnesota, New Jersey, Virginia, Tennessee, and Colorado will remain especially important commercial targets, although rural states also present meaningful opportunities for remote monitoring and distributed specialty care.

The competitive landscape will increasingly favor companies able to integrate medical-grade sensing, therapeutic capability, data transmission, analytics, clinical workflow, cybersecurity, and recurring service. Connectivity itself will progressively become expected. The strategic question for manufacturers will be whether the connected device produces information that changes care quickly enough, reliably enough, and economically enough to justify deployment at scale.

For clients evaluating the U.S. Connected Medical Devices Market, the decisive opportunities are therefore not limited to identifying which device categories will grow fastest. Buyers of this report need to understand which connected technologies can gain reimbursement-supported adoption, which care settings have the strongest workflow economics, how cyber-device requirements alter product lifecycle costs, which states and health systems offer the best commercial entry points, and which competitors are building defensible platforms rather than isolated products.

The next decade will transform connected medical devices from an adjacent digital-health category into core U.S. clinical infrastructure. Companies that combine validated medical-device performance with low-friction connectivity, interoperable data, strong cybersecurity, efficient clinical workflows, and measurable healthcare economics will be best positioned to capture the value created by that transition.

 

TABLE OF CONTENT

1. U.S. Connected Medical Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Connected Medical Device Manufacturers
1.6.2. Sensor, Semiconductor and Component Suppliers
1.6.3. Connectivity, Cloud and Medical Device Integration Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Specialty Clinics and Physician Practices
1.6.6. Home Healthcare and Remote Patient Monitoring Providers
1.6.7. Group Purchasing Organizations, Distributors and Channel Partners
1.6.8. Payers, Regulators, Cybersecurity Teams and Clinical Decision-Makers

What this section provides: This section establishes the market definition, inclusion and exclusion criteria, study methodology, assumptions, value-chain boundaries, and stakeholder ecosystem so clients understand how the U.S. Connected Medical Devices Market is measured, modeled, and validated.

2. U.S. Connected Medical Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.8. Connected Device Adoption Heatmap
2.9. Key Investment and Commercialization Themes

What this section provides: This section gives decision-makers a concise view of market size, historical expansion, forecast direction, connected-device adoption intensity, fastest-growing revenue pools, competitive pressure, and priority commercial opportunities through 2035.

3. U.S. Connected Medical Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Chronic Disease Burden and Aging U.S. Population
3.1.2. Expansion of Remote Patient Monitoring and Virtual Care
3.1.3. Growth of Continuous Physiological Monitoring
3.1.4. Hospital Workforce Constraints and Clinical Workflow Automation
3.1.5. Shift Toward Home-Based and Post-Acute Care
3.1.6. Growth of Connected Diabetes and Cardiac Monitoring Ecosystems
3.1.7. Increasing EHR and Clinical Workflow Interoperability
3.1.8. Expansion of Reimbursement-Supported Remote Monitoring
3.2. Restraints and Their Impact Analysis
3.2.1. Medical Device Cybersecurity and Data Breach Risk
3.2.2. Device Interoperability and Integration Complexity
3.2.3. High Implementation and Enterprise Integration Costs
3.2.4. Reimbursement Variability Across Connected Care Models
3.2.5. Alert Fatigue and Clinical Data Overload
3.2.6. Patient Connectivity, Digital Literacy and Adherence Barriers
3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Enabled Continuous Monitoring and Clinical Triage
3.3.2. Hospital-at-Home and Virtual Ward Expansion
3.3.3. Connected Implantable Device Monitoring
3.3.4. Closed-Loop and Semi-Automated Therapeutic Systems
3.3.5. Cellular-Enabled Remote Medical Devices
3.3.6. Longer-Wear Medical Sensors and Wearable Biosensors
3.3.7. Enterprise Device Management and Predictive Maintenance
3.3.8. Rural and Underserved Population Monitoring
3.4. Challenges and Their Impact Analysis
3.4.1. Software Lifecycle and Cybersecurity Patch Management
3.4.2. Multi-Vendor Hospital Device Integration
3.4.3. Clinical Validation of Algorithm-Generated Insights
3.4.4. Device Data Governance and Liability
3.4.5. Scalability of Remote Monitoring Operations
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Remote Patient Monitoring Program Economics
3.9. Connected Device Total Cost of Ownership Analysis

What this section provides: This section explains the clinical, technological, economic, reimbursement, cybersecurity, and operational factors influencing connected-device demand and helps clients assess both market upside and implementation risk.

4. U.S. Connected Medical Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Internet of Medical Things and Connected Care Ecosystem Analysis
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework for Connected and Cyber Medical Devices
4.8. Medical Device Cybersecurity Lifecycle Requirements
4.9. CMS Remote Patient Monitoring Reimbursement and Coverage Landscape
4.10. HIPAA, Health Data Privacy and Connected Device Governance
4.11. Interoperability, APIs and EHR Integration Landscape
4.12. Import/Export Restrictions & Tariff Impact
4.13. Government Initiatives and Digital Health Programs
4.14. Impact of Escalating Geopolitical and Semiconductor Supply Risks
4.15. Hospital Value Analysis Committee Decision Framework
4.16. Enterprise Medical Device Cybersecurity Procurement Framework

What this section provides: This section gives clients a comprehensive view of the external connected-device operating environment, including FDA regulation, cybersecurity, reimbursement, interoperability, pricing, supply chain, data governance, hospital procurement, and digital-health infrastructure.

5. U.S. Connected Medical Devices Market – By Device Type

5.1. Overview
5.1.1. Segment Share Analysis, By Device Type, 2025 & 2035 (%)
5.1.2. Connected Patient Monitoring Devices
5.1.2.1. Multi-Parameter Patient Monitors
5.1.2.2. Connected Blood Pressure Monitors
5.1.2.3. Pulse Oximeters
5.1.2.4. Connected ECG and Cardiac Monitors
5.1.2.5. Connected Respiratory Monitoring Devices
5.1.2.6. Connected Weight and Temperature Monitoring Devices
5.1.3. Wearable Medical Devices
5.1.3.1. Medical-Grade Wearable Sensors
5.1.3.2. Wearable ECG Patches
5.1.3.3. Continuous Glucose Monitoring Systems
5.1.3.4. Medical Smartwatches
5.1.3.5. Wearable Sleep and Respiratory Monitoring Devices
5.1.3.6. Multi-Parameter Biosensor Patches
5.1.4. Connected Therapeutic and Drug-Delivery Devices
5.1.4.1. Connected Insulin Pumps
5.1.4.2. Smart Infusion Systems
5.1.4.3. Connected Respiratory Therapy Devices
5.1.4.4. Connected Dialysis Systems
5.1.4.5. Connected Neurostimulation Devices
5.1.4.6. Smart Medication Delivery Devices
5.1.5. Connected Diagnostic and Imaging Devices
5.1.5.1. Connected Ultrasound Systems
5.1.5.2. Connected Point-of-Care Diagnostic Devices
5.1.5.3. Networked Imaging Systems
5.1.5.4. Connected Laboratory Diagnostic Devices
5.1.5.5. Portable and Handheld Connected Diagnostics
5.1.6. Connected Implantable Medical Devices
5.1.6.1. Connected Pacemakers
5.1.6.2. Implantable Cardioverter Defibrillators
5.1.6.3. Implantable Cardiac Monitors
5.1.6.4. Implantable Hemodynamic Monitoring Systems
5.1.6.5. Connected Neurostimulation Implants
5.1.6.6. Other Connected Implantable Devices

What this section provides: This section identifies which connected medical device categories generate the highest revenue, which subsegments are moving toward recurring data-enabled business models, and which device types are expected to deliver the strongest growth through 2035.

6. U.S. Connected Medical Devices Market – By Connectivity Technology

6.1. Overview
6.1.1. Segment Share Analysis, By Connectivity Technology, 2025 & 2035 (%)
6.1.2. Wi-Fi
6.1.2.1. Hospital Wi-Fi Medical Device Connectivity
6.1.2.2. Home Wi-Fi Connected Medical Devices
6.1.2.3. Enterprise Wireless Device Networks
6.1.3. Bluetooth and Bluetooth Low Energy
6.1.3.1. Smartphone-Connected Medical Devices
6.1.3.2. Wearable Sensor Connectivity
6.1.3.3. Gateway-Based BLE Medical Devices
6.1.4. Cellular, LTE and 5G
6.1.4.1. Embedded Cellular Medical Devices
6.1.4.2. LTE-Enabled Remote Monitoring Devices
6.1.4.3. 5G-Enabled Medical Applications
6.1.4.4. Cellular Medical Device Gateways
6.1.5. NFC and RFID
6.1.5.1. Medical Device Identification
6.1.5.2. Patient-Device Authentication
6.1.5.3. Asset and Inventory Tracking
6.1.5.4. Medication and Consumable Tracking
6.1.6. Other Wireless and Hybrid Connectivity Technologies
6.1.6.1. Proprietary Wireless Protocols
6.1.6.2. Low-Power Wide-Area Connectivity
6.1.6.3. Wired-Wireless Hybrid Systems
6.1.6.4. Edge-Connected Medical Device Architectures

What this section provides: This section evaluates the communication technologies supporting connected medical devices and highlights how bandwidth, battery life, reliability, hospital network architecture, patient usability, cybersecurity, and coverage influence technology adoption.

7. U.S. Connected Medical Devices Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Remote Patient Monitoring and Chronic Disease Management
7.1.2.1. Hypertension Monitoring
7.1.2.2. Heart Failure Monitoring
7.1.2.3. Chronic Respiratory Disease Monitoring
7.1.2.4. Post-Discharge Monitoring
7.1.2.5. Multi-Chronic Condition Monitoring
7.1.3. Inpatient Patient Monitoring and Clinical Workflow
7.1.3.1. Intensive and Critical Care Monitoring
7.1.3.2. General Ward Continuous Monitoring
7.1.3.3. Emergency Department Monitoring
7.1.3.4. Perioperative and Post-Anesthesia Monitoring
7.1.3.5. Smart Infusion and Medication Workflow
7.1.4. Cardiac and Vital-Sign Monitoring
7.1.4.1. Ambulatory ECG Monitoring
7.1.4.2. Mobile Cardiac Telemetry
7.1.4.3. Implantable Rhythm Monitoring
7.1.4.4. Remote Pacemaker and ICD Monitoring
7.1.4.5. Connected Blood Pressure and Vital-Sign Monitoring
7.1.5. Diabetes and Metabolic Management
7.1.5.1. Continuous Glucose Monitoring
7.1.5.2. Connected Insulin Delivery
7.1.5.3. Automated Insulin Delivery Systems
7.1.5.4. Metabolic and Weight Monitoring
7.1.6. Medication Delivery, Post-Acute Care and Other Applications
7.1.6.1. Connected Drug Delivery
7.1.6.2. Respiratory and Sleep Management
7.1.6.3. Rehabilitation Monitoring
7.1.6.4. Hospital-at-Home Monitoring
7.1.6.5. Connected Renal Care
7.1.6.6. Other Specialty Applications

What this section provides: This section helps clients understand demand by clinical use case and identify applications where connected devices have the strongest combination of patient volume, reimbursement potential, workflow impact, recurring revenue, and clinical need.

8. U.S. Connected Medical Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Academic Medical Centers
8.1.2.2. Community Hospitals
8.1.2.3. Integrated Delivery Networks
8.1.2.4. Specialty Hospitals
8.1.3. Specialty Clinics and Physician Practices
8.1.3.1. Cardiology Practices
8.1.3.2. Endocrinology and Diabetes Centers
8.1.3.3. Pulmonology and Sleep Clinics
8.1.3.4. Nephrology Practices
8.1.3.5. Neurology and Other Specialty Practices
8.1.4. Home Healthcare and Remote Monitoring Providers
8.1.4.1. Hospital-at-Home Programs
8.1.4.2. Remote Patient Monitoring Service Providers
8.1.4.3. Home Health Agencies
8.1.4.4. Virtual Care Platforms
8.1.5. Ambulatory Surgery Centers and Post-Acute Facilities
8.1.5.1. Ambulatory Surgery Centers
8.1.5.2. Skilled Nursing Facilities
8.1.5.3. Rehabilitation Facilities
8.1.5.4. Long-Term Care Facilities
8.1.6. Diagnostic Centers, Laboratories and Other Providers
8.1.6.1. Diagnostic Imaging Centers
8.1.6.2. Independent Laboratories
8.1.6.3. Urgent Care Centers
8.1.6.4. Retail and Decentralized Clinical Sites

What this section provides: This section explains which healthcare settings are expected to drive device purchasing, enterprise connectivity investment, remote monitoring enrollment, recurring sensor use, and digital clinical workflow adoption.

9. U.S. Connected Medical Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Supplier Sales
9.1.6. Remote Patient Monitoring and Digital Care Platform Procurement
9.1.7. Physician Practice and Ambulatory Direct Procurement
9.1.8. Pharmacy and Patient-Directed Distribution Channels

What this section provides: This section explains how connected medical devices are purchased and deployed in the U.S., including direct hospital contracting, IDN standardization, GPO influence, specialty distribution, RPM-platform procurement, physician purchasing, and patient-directed channels.

10. U.S. Connected Medical Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital, Chronic Disease and Digital Health Infrastructure Analysis
10.1.4. Regional Remote Patient Monitoring Adoption Analysis
10.1.5. Regional Reimbursement and Procurement Dynamics
10.1.6. Regional Connected Device Cybersecurity and Interoperability Readiness
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Connected Medical Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Connected Medical Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Connected Medical Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Connected Medical Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed four-region and 50-state analysis to help clients identify connected-device adoption hotspots, high-value health-system markets, remote-monitoring opportunities, digital infrastructure advantages, chronic-disease demand centers, and state-level commercialization priorities.

11. U.S. Connected Medical Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking by Device Portfolio
11.4. Competitive Benchmarking by Connectivity and Digital Capabilities
11.5. Company Profiles
11.5.1. Abbott Laboratories
11.5.2. Medtronic
11.5.3. GE HealthCare
11.5.4. Philips
11.5.5. Siemens Healthineers
11.5.6. Baxter International
11.5.7. DexCom
11.5.8. Boston Scientific Corporation
11.5.9. Johnson & Johnson MedTech
11.5.10. Masimo Corporation
11.5.11. iRhythm Technologies
11.5.12. ResMed
11.5.13. Becton, Dickinson and Company
11.5.14. Insulet Corporation
11.5.15. Tandem Diabetes Care
11.5.16. Omron Healthcare
11.5.17. BioIntelliSense
11.5.18. AliveCor
11.5.19. ZOLL Medical Corporation
11.5.20. Edwards Lifesciences
11.5.21. Nihon Kohden America
11.5.22. Roche Diagnostics
11.5.23. Dräger
11.5.24. Mindray North America
11.5.25. Fresenius Medical Care

Note: Each company profile will include company overview, connected medical device portfolio, U.S. market strategy, installed-base positioning, connectivity architecture, software and recurring-revenue strategy, regulatory status, cybersecurity capabilities, partnerships, acquisitions, product pipeline, and recent developments.

What this section provides: This section gives clients market-share visibility, competitor benchmarking, portfolio positioning, interoperability capabilities, digital ecosystem strategy, recurring-revenue exposure, innovation direction, and strategic intelligence on leading U.S. connected medical device companies.

12. U.S. Connected Medical Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Enabled Continuous Physiological Monitoring
12.2.2. Medical-Grade Wearable Biosensors
12.2.3. Closed-Loop Connected Therapeutic Systems
12.2.4. Edge AI and On-Device Clinical Intelligence
12.2.5. 5G and Cellular Medical Device Connectivity
12.2.6. Digital Biomarkers
12.2.7. Interoperable Medical Device Platforms
12.2.8. Predictive Device Maintenance
12.2.9. Cybersecurity-by-Design Architectures
12.2.10. Hospital-at-Home Device Ecosystems
12.3. Emerging Business Trends
12.3.1. Hardware-to-Platform Business Model Transition
12.3.2. Recurring Sensor and Subscription Revenue
12.3.3. Device-as-a-Service Models
12.3.4. Enterprise Connected Device Standardization
12.3.5. Manufacturer-RPM Provider Partnerships
12.3.6. Device Data Monetization and Outcomes Analytics
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Technology Adoption Curve, 2026–2035
12.7. Connected Device Replacement and Upgrade Cycle Analysis
12.8. Future Hospital Connectivity Architecture

What this section provides: This section prepares clients for emerging technology shifts, connected-device business model changes, adoption scenarios, investment themes, future hospital architecture, and high-growth opportunities expected to reshape the U.S. market through 2035.

13. U.S. Connected Medical Devices Market: Strategic Recommendations

13.1. Recommendations for Connected Medical Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Remote Patient Monitoring Providers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. U.S. Go-to-Market Strategy Considerations
13.8. Product Positioning and Portfolio Expansion Guidance
13.9. Hospital Enterprise Contracting Strategy
13.10. Reimbursement and Economic Evidence Strategy
13.11. Cybersecurity and Interoperability Positioning Strategy
13.12. State-Level Commercial Prioritization Strategy

What this section provides: This section converts the market intelligence into actionable recommendations for product development, commercialization, hospital contracting, reimbursement planning, cybersecurity differentiation, channel expansion, capital allocation, geographic prioritization, and competitive positioning.

14. U.S. Connected Medical Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Market Definition and Double-Counting Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
14.7. Regulatory and Reimbursement Change Disclaimer
14.8. Cybersecurity and Technology Evolution Disclaimer

What this section provides: This section clarifies the report’s market boundaries, data-use conditions, forecasting assumptions, regulatory limitations, connected-device scope, cybersecurity considerations, and legal terms governing interpretation of the research.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Connected Medical Devices Market: Market Definition and Scope
TABLE 3: U.S. Connected Medical Devices Market: Research Methodology Framework
TABLE 4: U.S. Connected Medical Devices Market: Key Assumptions
TABLE 5: U.S. Connected Medical Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Connected Medical Devices Market: Stakeholder Analysis
TABLE 7: U.S. Connected Medical Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Connected Medical Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Connected Medical Devices Market: Market Attractiveness Index
TABLE 10: U.S. Connected Medical Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Connected Medical Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Connected Medical Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Connected Medical Devices Market: High-Growth Opportunity Areas
TABLE 14: U.S. Connected Medical Devices Market: Connected Device Adoption Heatmap
TABLE 15: U.S. Connected Medical Devices Market: Drivers; Impact Analysis
TABLE 16: U.S. Connected Medical Devices Market: Restraints; Impact Analysis
TABLE 17: U.S. Connected Medical Devices Market: Opportunities; Impact Analysis
TABLE 18: U.S. Connected Medical Devices Market: Challenges; Impact Analysis
TABLE 19: U.S. Connected Medical Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Connected Medical Devices Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Connected Medical Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Connected Medical Devices Market: Remote Patient Monitoring Program Economics
TABLE 23: U.S. Connected Medical Devices Market: Connected Device Total Cost of Ownership Matrix
TABLE 24: U.S. Connected Medical Devices Market: PESTEL Analysis
TABLE 25: U.S. Connected Medical Devices Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Connected Medical Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. Connected Medical Devices Market: Value Chain Analysis
TABLE 28: U.S. Connected Medical Devices Market: Supply Chain Analysis
TABLE 29: U.S. Connected Medical Devices Market: IoMT and Connected Care Ecosystem Analysis
TABLE 30: U.S. Connected Medical Devices Market: Application & Innovation Landscape
TABLE 31: U.S. Connected Medical Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Connected Medical Devices Market: Medical Device Cybersecurity Lifecycle Framework
TABLE 33: U.S. Connected Medical Devices Market: CMS Remote Patient Monitoring Reimbursement Landscape
TABLE 34: U.S. Connected Medical Devices Market: HIPAA and Connected Device Data Governance
TABLE 35: U.S. Connected Medical Devices Market: Interoperability, API and EHR Integration Landscape
TABLE 36: U.S. Connected Medical Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 37: U.S. Connected Medical Devices Market: Government Digital Health Initiatives
TABLE 38: U.S. Connected Medical Devices Market: Semiconductor and Geopolitical Supply Risk
TABLE 39: U.S. Connected Medical Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 40: U.S. Connected Medical Devices Market: Enterprise Cybersecurity Procurement Framework
TABLE 41: U.S. Connected Medical Devices Market: Device Type Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Device Type
TABLE 43: U.S. Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 44: U.S. Connected Medical Devices Market: Segment Share Analysis, by Device Type, 2025 & 2035 (%)
TABLE 45: Connected Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: Wearable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: Connected Therapeutic and Drug-Delivery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: Connected Diagnostic and Imaging Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Connected Implantable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Connected Medical Devices Market: Connectivity Technology Snapshot, 2025
TABLE 51: Segment Dashboard; Definition and Scope, by Connectivity Technology
TABLE 52: U.S. Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 53: U.S. Connected Medical Devices Market: Connectivity Technology Share Analysis, 2025 & 2035 (%)
TABLE 54: Wi-Fi Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Bluetooth and Bluetooth Low Energy Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Cellular, LTE and 5G Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: NFC and RFID Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: Other Wireless and Hybrid Connectivity Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Connected Medical Devices Market: Application Snapshot, 2025
TABLE 60: Segment Dashboard; Definition and Scope, by Application
TABLE 61: U.S. Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 62: U.S. Connected Medical Devices Market: Application Share Analysis, 2025 & 2035 (%)
TABLE 63: Remote Patient Monitoring and Chronic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Inpatient Patient Monitoring and Clinical Workflow Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Cardiac and Vital-Sign Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: Diabetes and Metabolic Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: Medication Delivery, Post-Acute Care and Other Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Connected Medical Devices Market: End User Snapshot, 2025
TABLE 69: Segment Dashboard; Definition and Scope, by End User
TABLE 70: U.S. Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 71: U.S. Connected Medical Devices Market: End User Share Analysis, 2025 & 2035 (%)
TABLE 72: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Specialty Clinics and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Home Healthcare and Remote Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Ambulatory Surgery Centers and Post-Acute Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: Diagnostic Centers, Laboratories and Other Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Connected Medical Devices Market: Procurement Channel Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 79: U.S. Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 80: U.S. Connected Medical Devices Market: Procurement Channel Share Analysis, 2025 & 2035 (%)
TABLE 81: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: Remote Patient Monitoring and Digital Care Platform Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: Physician Practice, Pharmacy and Patient-Directed Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Connected Medical Devices Market: Regional Snapshot, 2025
TABLE 88: Segment Dashboard; Definition and Scope, by Region
TABLE 89: U.S. Connected Medical Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 90: U.S. Connected Medical Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 91: U.S. Connected Medical Devices Market: Regional Digital Health and Hospital Infrastructure Comparison
TABLE 92: U.S. Connected Medical Devices Market: Regional RPM Adoption and Procurement Dynamics
TABLE 93: West Region U.S. Connected Medical Devices Market: Regional Overview and Trends
TABLE 94: West Region U.S. Connected Medical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 95: West Region U.S. Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 99: West Region U.S. Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 100: West Region U.S. Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 101: California Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Washington Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Arizona Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Colorado Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Oregon Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Utah Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Nevada Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: New Mexico Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Idaho Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Montana Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Wyoming Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Alaska Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Hawaii Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Connected Medical Devices Market: Regional Overview and Trends
TABLE 115: Northeast Region U.S. Connected Medical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 116: Northeast Region U.S. Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region U.S. Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region U.S. Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 120: Northeast Region U.S. Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 121: Northeast Region U.S. Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 122: New York Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Massachusetts Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: New Jersey Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Pennsylvania Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Connecticut Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Maine Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Vermont Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: New Hampshire Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Rhode Island Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Delaware Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: South Region U.S. Connected Medical Devices Market: Regional Overview and Trends
TABLE 133: South Region U.S. Connected Medical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 134: South Region U.S. Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 136: South Region U.S. Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 137: South Region U.S. Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 138: South Region U.S. Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: South Region U.S. Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: Texas Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Florida Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Georgia Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: North Carolina Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Tennessee Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: South Carolina Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Alabama Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Mississippi Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Louisiana Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Arkansas Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Kentucky Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Oklahoma Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Virginia Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Maryland Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: West Virginia Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Midwest Region U.S. Connected Medical Devices Market: Regional Overview and Trends
TABLE 156: Midwest Region U.S. Connected Medical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 157: Midwest Region U.S. Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 159: Midwest Region U.S. Connected Medical Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region U.S. Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Midwest Region U.S. Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Midwest Region U.S. Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: Illinois Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Ohio Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Michigan Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Minnesota Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Indiana Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Wisconsin Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Missouri Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Iowa Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: Kansas Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: Nebraska Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: North Dakota Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 174: South Dakota Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 175: U.S. Connected Medical Devices Market: Competitive Landscape Snapshot, 2025
TABLE 176: U.S. Connected Medical Devices Market: Key Company Market Share Analysis, 2025
TABLE 177: U.S. Connected Medical Devices Market: Company Positioning Matrix
TABLE 178: U.S. Connected Medical Devices Market: Device Portfolio Benchmarking of Key Players
TABLE 179: U.S. Connected Medical Devices Market: Connectivity and Digital Capability Benchmarking
TABLE 180: U.S. Connected Medical Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 181: Abbott Laboratories: Company Profile
TABLE 182: Medtronic: Company Profile
TABLE 183: GE HealthCare: Company Profile
TABLE 184: Philips: Company Profile
TABLE 185: Siemens Healthineers: Company Profile
TABLE 186: Baxter International: Company Profile
TABLE 187: DexCom: Company Profile
TABLE 188: Boston Scientific Corporation: Company Profile
TABLE 189: Johnson & Johnson MedTech: Company Profile
TABLE 190: Masimo Corporation: Company Profile
TABLE 191: iRhythm Technologies: Company Profile
TABLE 192: ResMed: Company Profile
TABLE 193: Becton, Dickinson and Company: Company Profile
TABLE 194: Insulet Corporation: Company Profile
TABLE 195: Tandem Diabetes Care: Company Profile
TABLE 196: Omron Healthcare: Company Profile
TABLE 197: BioIntelliSense: Company Profile
TABLE 198: AliveCor: Company Profile
TABLE 199: ZOLL Medical Corporation: Company Profile
TABLE 200: Edwards Lifesciences: Company Profile
TABLE 201: Nihon Kohden America: Company Profile
TABLE 202: Roche Diagnostics: Company Profile
TABLE 203: Dräger: Company Profile
TABLE 204: Mindray North America: Company Profile
TABLE 205: Fresenius Medical Care: Company Profile
TABLE 206: U.S. Connected Medical Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 207: U.S. Connected Medical Devices Market: Disruptive Technologies Impact Matrix
TABLE 208: U.S. Connected Medical Devices Market: Emerging Business Trends
TABLE 209: U.S. Connected Medical Devices Market: Business Opportunities for Startups and Existing Players
TABLE 210: U.S. Connected Medical Devices Market: Investment Prioritization Matrix
TABLE 211: U.S. Connected Medical Devices Market: Technology Adoption Curve, 2026–2035
TABLE 212: U.S. Connected Medical Devices Market: Connected Device Replacement and Upgrade Cycle
TABLE 213: U.S. Connected Medical Devices Market: Future Hospital Connectivity Architecture
TABLE 214: U.S. Connected Medical Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 215: U.S. Connected Medical Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 216: U.S. Connected Medical Devices Market: Strategic Recommendations for Remote Patient Monitoring Providers
TABLE 217: U.S. Connected Medical Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 218: U.S. Connected Medical Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 219: U.S. Connected Medical Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 220: U.S. Connected Medical Devices Market: Go-to-Market Strategy Considerations
TABLE 221: U.S. Connected Medical Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 222: U.S. Connected Medical Devices Market: Hospital Enterprise Contracting Strategy
TABLE 223: U.S. Connected Medical Devices Market: Reimbursement and Economic Evidence Strategy
TABLE 224: U.S. Connected Medical Devices Market: Cybersecurity and Interoperability Positioning Strategy
TABLE 225: U.S. Connected Medical Devices Market: State-Level Commercial Prioritization Strategy
TABLE 226: U.S. Connected Medical Devices Market: Scope Limitation
TABLE 227: U.S. Connected Medical Devices Market: Data Use Limitation
TABLE 228: U.S. Connected Medical Devices Market: Forecasting Limitation
TABLE 229: U.S. Connected Medical Devices Market: Market Definition and Double-Counting Limitation
TABLE 230: U.S. Connected Medical Devices Market: Legal Disclaimer
TABLE 231: U.S. Connected Medical Devices Market: Third-Party Data Disclaimer
TABLE 232: U.S. Connected Medical Devices Market: Regulatory and Reimbursement Change Disclaimer
TABLE 233: U.S. Connected Medical Devices Market: Cybersecurity and Technology Evolution Disclaimer

List of Figures

FIGURE 1: U.S. Connected Medical Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Connected Medical Devices Market Ecosystem
FIGURE 4: Stakeholder Ecosystem Analysis
FIGURE 5: U.S. Connected Medical Devices Market Attractiveness Analysis
FIGURE 6: U.S. Connected Medical Devices Market Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. Connected Medical Devices Market Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. Connected Medical Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 9: Connected Medical Device Adoption Heatmap
FIGURE 10: U.S. Connected Medical Devices Market Dynamics
FIGURE 11: Innovation & Patent Landscape, 2021–2025
FIGURE 12: Clinical Workflow Economics Framework
FIGURE 13: Hospital Capital Procurement Decision Framework
FIGURE 14: Remote Patient Monitoring Program Economics Framework
FIGURE 15: Connected Device Total Cost of Ownership Framework
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Connected Medical Device Value Chain Analysis
FIGURE 19: Connected Medical Device Supply Chain Analysis
FIGURE 20: IoMT and Connected Care Ecosystem
FIGURE 21: FDA Connected and Cyber Medical Device Regulatory Framework
FIGURE 22: Medical Device Cybersecurity Lifecycle Framework
FIGURE 23: CMS Remote Patient Monitoring Reimbursement Framework
FIGURE 24: Connected Medical Device Interoperability and EHR Integration Architecture
FIGURE 25: Hospital Value Analysis Committee Decision Framework
FIGURE 26: Enterprise Connected Device Cybersecurity Procurement Framework
FIGURE 27: Device Type Segment Market Share Analysis, 2025 & 2035
FIGURE 28: Device Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Connected Patient Monitoring Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 30: Wearable Medical Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 31: Connected Therapeutic and Drug-Delivery Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 32: Connected Diagnostic and Imaging Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 33: Connected Implantable Medical Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 34: Connectivity Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 35: Connectivity Technology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Wi-Fi Connected Medical Devices Market Growth, 2021–2035
FIGURE 37: Bluetooth and BLE Connected Medical Devices Market Growth, 2021–2035
FIGURE 38: Cellular, LTE and 5G Connected Medical Devices Market Growth, 2021–2035
FIGURE 39: NFC, RFID and Hybrid Connectivity Technology Outlook
FIGURE 40: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Remote Patient Monitoring and Chronic Disease Management Growth, 2021–2035
FIGURE 43: Inpatient Patient Monitoring and Clinical Workflow Growth, 2021–2035
FIGURE 44: Cardiac and Vital-Sign Monitoring Growth, 2021–2035
FIGURE 45: Diabetes and Metabolic Management Growth, 2021–2035
FIGURE 46: Medication Delivery and Post-Acute Connected Care Growth, 2021–2035
FIGURE 47: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 48: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Hospitals and Integrated Health Systems Market Growth, 2021–2035
FIGURE 50: Specialty Clinics and Physician Practices Market Growth, 2021–2035
FIGURE 51: Home Healthcare and Remote Monitoring Providers Market Growth, 2021–2035
FIGURE 52: Ambulatory and Post-Acute Connected Device Adoption Outlook
FIGURE 53: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 54: Procurement Channel Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Direct Hospital and IDN Procurement Growth Roadmap
FIGURE 56: RPM and Digital Care Platform Procurement Growth Roadmap
FIGURE 57: U.S. Connected Medical Devices Regional Market Share Analysis, 2025 & 2035
FIGURE 58: U.S. Connected Medical Devices Regional Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 59: West Region U.S. Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 60: West Region Market Share Analysis by State, 2025
FIGURE 61: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: California Connected Medical Devices Market Growth Outlook, 2021–2035
FIGURE 63: Washington, Arizona and Colorado Connected Medical Devices Market Growth Outlook
FIGURE 64: Oregon, Utah and Nevada Connected Medical Devices Market Growth Outlook
FIGURE 65: New Mexico, Idaho, Montana, Wyoming, Alaska and Hawaii Market Opportunity Map
FIGURE 66: Northeast Region U.S. Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 67: Northeast Region Market Share Analysis by State, 2025
FIGURE 68: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: New York and Massachusetts Connected Medical Devices Market Growth Outlook
FIGURE 70: Pennsylvania, New Jersey and Connecticut Connected Medical Devices Market Growth Outlook
FIGURE 71: Maine, Vermont, New Hampshire, Rhode Island and Delaware Market Opportunity Map
FIGURE 72: South Region U.S. Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 73: South Region Market Share Analysis by State, 2025
FIGURE 74: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Texas and Florida Connected Medical Devices Market Growth Outlook
FIGURE 76: Georgia, North Carolina, Tennessee and Virginia Connected Medical Devices Market Growth Outlook
FIGURE 77: South Carolina, Alabama, Mississippi, Louisiana and Arkansas Market Opportunity Map
FIGURE 78: Kentucky, Oklahoma, Maryland and West Virginia Market Opportunity Map
FIGURE 79: Midwest Region U.S. Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 80: Midwest Region Market Share Analysis by State, 2025
FIGURE 81: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Illinois, Ohio, Michigan and Minnesota Connected Medical Devices Market Growth Outlook
FIGURE 83: Indiana, Wisconsin and Missouri Connected Medical Devices Market Growth Outlook
FIGURE 84: Iowa, Kansas, Nebraska, North Dakota and South Dakota Market Opportunity Map
FIGURE 85: U.S. Connected Medical Devices Market Competitive Landscape; Key Company Market Share, 2025
FIGURE 86: Company Positioning Matrix
FIGURE 87: Key Player Device Portfolio Benchmarking
FIGURE 88: Key Player Connectivity and Digital Capability Benchmarking
FIGURE 89: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 90: U.S. Connected Medical Devices Innovation Roadmap
FIGURE 91: Continuous Monitoring and Wearable Biosensor Adoption Roadmap
FIGURE 92: Connected Diabetes Technology Opportunity Map
FIGURE 93: Remote Cardiac Monitoring Growth Roadmap
FIGURE 94: Hospital-at-Home Connected Device Opportunity Map
FIGURE 95: AI-Enabled Connected Medical Device Adoption Roadmap
FIGURE 96: U.S. Connected Medical Devices Future Market Scenario Analysis, 2026–2035
FIGURE 97: Disruptive Technologies Impact Matrix
FIGURE 98: Emerging Business Trends Matrix
FIGURE 99: Connected Device Technology Adoption Curve, 2026–2035
FIGURE 100: Connected Device Replacement and Upgrade Cycle
FIGURE 101: Future Hospital Connectivity Architecture
FIGURE 102: Investment Prioritization Matrix
FIGURE 103: Strategic Growth Roadmap for U.S. Connected Medical Device Companies
FIGURE 104: Go-to-Market Strategy Framework
FIGURE 105: Product Positioning and Portfolio Expansion Framework
FIGURE 106: Hospital Enterprise Contracting Framework
FIGURE 107: Reimbursement and Economic Evidence Strategy Framework
FIGURE 108: Cybersecurity and Interoperability Positioning Framework
FIGURE 109: State-Level Commercial Prioritization Framework
FIGURE 110: Report Scope, Forecasting and Disclaimer Framework